T2D Trademark Details
Word Mark | T2d |
---|---|
Status | Alive 645 — Final Refusal - Mailed |
Current Owner
Serial Number | 86696547 |
---|---|
Status Date | Tuesday, May 24, 2016 |
Filing Date | Tuesday, May 24, 2016 |
Attorney | Janet L. Cullum |
Correspondent
JANET L. CULLUM
Cooley Llp
1299 Pennsylvania Ave NW Ste 700
Washington, DC 20004-2446
Cooley Llp
1299 Pennsylvania Ave NW Ste 700
Washington, DC 20004-2446
Case File Statements
Indication of Colors | Color is not claimed as a feature of the mark. |
---|---|
Description of Mark | The mark consists of capitalized three-dimensional letters T2D. |
Goods & Services | Pharmaceutical preparations for the treatment of obesity and metabolic diseases/disorders |
Goods & Services | Drug delivery systems; medical apparatus for the administration of pharmaceuticals; medical apparatus for treatment of obesity and metabolic diseases/disorders |
Goods & Services | Development and dissemination of educational materials of others in the fields of obesity, metabolic diseases/disorders, drug delivery technologies and administration of pharmaceuticals; educational services, namely, conducting classes, seminars, conferences, workshops, field trips and programs in the fields of obesity, metabolic diseases/disorders, and treatments relating thereto, drug delivery technologies and administration of pharmaceuticals, and distribution of educational material in connection therewith |
Goods & Services | Research and development of pharmaceutical preparations, products and technology in the fields of obesity and metabolic diseases/disorders, drug delivery technologies, and administration of pharmaceuticals; medical and scientific research in the fields of obesity, metabolic diseases/disorders, drug delivery technologies, and administration of pharmaceuticals; providing medical and scientific research information in the fields of obesity, metabolic diseases/disorders, drug delivery technologies, administration of pharmaceuticals, pharmaceuticals, and clinical trials; scientific investigations for medical purposes; medical research; design and testing of new products, technologies and therapies in the fields of metabolic diseases/disorders, drug delivery technologies, and administration of pharmaceuticals |
Goods & Services | Medical information services, namely, providing information on the topics of obesity and metabolic diseases/disorders and the diagnosis, treatment and management therapies relating thereto; providing information in the fields of medicine, drug delivery technologies, and administration of pharmaceuticals |
Pseudo Mark | T Two D |
Classifications
International Class Codes |
005
|
---|---|
U.S. Class Codes | 006, 018, 044, 046, 051, 052 |
Status | 6 — Active |
Status Date | Thursday, July 23, 2015 |
Primary Code | 005 |
International Class Codes |
010
|
---|---|
U.S. Class Codes | 026, 039, 044 |
Status | 6 — Active |
Status Date | Thursday, July 23, 2015 |
Primary Code | 010 |
International Class Codes |
041
|
---|---|
U.S. Class Codes | 100, 101, 107 |
Status | 6 — Active |
Status Date | Thursday, July 23, 2015 |
Primary Code | 041 |
International Class Codes |
042
|
---|---|
U.S. Class Codes | 100, 101 |
Status | 6 — Active |
Status Date | Thursday, July 23, 2015 |
Primary Code | 042 |
International Class Codes |
044
|
---|---|
U.S. Class Codes | 100, 101 |
Status | 6 — Active |
Status Date | Thursday, July 23, 2015 |
Primary Code | 044 |
Trademark Timeline
-
Jul 17 2015Trademark application filed with USPTO
-
Jul 20 2015New Application Entered In Tram
-
Jul 23 2015New Application Office Supplied Data Entered In Tram
-
Jul 24 2015Notice of Pseudo Mark E-Mailed
-
Oct 28 2015Assigned To Examiner
-
Nov 03 2015Notification of Non-Final Action E-Mailed
-
Nov 03 2015Non-Final Action E-Mailed
-
Nov 03 2015Non-Final Action Written
-
May 02 2016Correspondence Received In Law Office
-
May 02 2016Teas Response To Office Action Received
-
May 03 2016Teas/email Correspondence Entered
-
May 24 2016Notification of Final Refusal Emailed
-
May 24 2016Final Refusal E-Mailed
-
May 24 2016Final Refusal Written